Healthcare Finance News December 20, 2021
Jeff Lagasse

OIG found gaps between the number of providers authorized to treat patients with medication and the number of those who need care.

While more than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder in 2020, fewer than 16% of those beneficiaries received medication to treat their condition, according to a new report from the Office of Inspector General. They accounted for fewer than one in 6 of all Medicare beneficiaries with opioid use disorder.

Each of these 167,734 beneficiaries received at least one of the three approved drugs to treat opioid use disorder: buprenorphine, methadone, and naltrexone. The Food and Drug Administration recommends that all three of these drugs be available to all patients because certain medications...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Insurance, Medicare, OIG, Patient / Consumer, Provider, Survey / Study, Trends
Health care waste exposed [PODCAST]
March Fundraising Roundup: 7 Provider Tech Startups That Closed Rounds This Month
Nation's 1st double lung-liver transplant performed at Northwestern
The Ripple Effect: Ways to Make Health in All Policies Stick in Kansas and Beyond to Enhance Health and Equity
As Change reviews data impacted by cyberattack, here's what the notification process could look like

Share This Article